3rd Quarter - Report
W STRATEGIES, LLC for ALEXION PHARMACEUTICALS
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Education about the value of innovative new medicines and the Orphan Drug Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
S.2543: Prescription Drug Pricing Reduction Act of 2019. Regulatory and legislative proposals in the Administration's Rx Blueprint. H.R.3: Lower Drug Costs Now Act of 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.